Port-Wine Stain: Clinical Trials

4 trials for Port-Wine Stain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow Port-Wine Stain: new trials by email Literature Review of Port-Wine Stain trials Research Report on Port-Wine Stain

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pilot Study of Hemoporfin PDT in Children(2-7 Years Old) With Port-wine Stain
Hemoporfin PDT - Port-wine Stain
Phase 4CompletedShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.402020-05-272023-12-20
A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology
Haemoblock, Placebo - Vascular Diseases, Vascular Malformation
Phase 4CompletedCenter for Vascular Pathology, Moscow2002020-01-012021-11-04
Postmarketing Safety Study of Hemoporfin in Patients With Port Wine Stain
Hemoporfin - Port-Wine Stain
Phase 4CompletedShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.5012017-08-312023-12-20
A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain
Hemoporfin PDT - Port-wine Stain
Phase 4CompletedShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.242017-08-022020-08-13

Narrower conditions

Capillary Malformation-Arteriovenous Malformation (1)  ·  Capillary Malformations, Congenital, 1 (1)  ·  Sturge-Weber Syndrome (1)  ·  Vascular Diseases (1)  ·  Vascular Malformations (1)  ·  Vascular Neoplasms (1)

Broader conditions

Congenital Abnormalities (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Skin Abnormalities (4)  ·  Skin Diseases (4)  ·  Skin and Connective Tissue Diseases (4)  ·  Angiomatosis (1)  ·  Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Hemangioma (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Vascular Tissue (1)  ·  Nervous System Diseases (1)  ·  Neurocutaneous Syndromes (1)

Interventions

hematoporphyrin monomethyl ether (1)

Sponsors

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (3)  ·  Center for Vascular Pathology, Moscow (1)

Countries

China (3)  ·  Russia (1)

Top investigators

Jining Tao (2)  ·  Alexander Plotkin, PhD (1)  ·  Dmitry V Romanov, MD (1)  ·  Ekaterina M Listovskaya, BSc (1)  ·  Lin Ma, MD (1)  ·  Xuejun Zhu (1)